The company intends to use the funds to continue to invest in the launch of its three commercial products to accelerate revenue growth, which they intend to reinvest in their pipeline and platform.

Company Information

Company Status

Private & Independent

Industry

Software

Mailing Address

200 State St.
Boston, MA 02109
USA

Phone

Undisclosed

Website

www.peartherapeutics.com

Email Address

[email protected]

Overview

Pear Therapeutics' patented eFormulation approach combines mobile health apps with supplements, medical foods, and pharmaceuticals, to create more efficacious treatment solutions. eFormulations are simple to use. A software access code on the product packaging provides access to Pear's health apps.

Profile

Social Media

Pear Therapeutics Company Twitter Account

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Corey McCann

Chief Medical Officer

Yuri Maricich

Chief Operating Officer

Christopher Guiffre

Vice President

Catherine Cushenberry

Vice President

Mark Deeg

Vice President

Michael Pace

VP - Bus. Development

Julia Strandberg

VP - Bus. Development

Alex Waldron

VP - Engineering

Gordon Kass

VP - General Counsel

Ronan O'Brien

VP - Human Resources

Kathy Jeffery

VP - Marketing

Kirsten Carlson

VP - Product Management

Kathleen Bauman

VP - Product Management

Erin Brenner

VP - Regulatory Affairs

Steve Sherman

VP - Sales

Brian Prunier

Browse more venture capital transactions:

Prev: 12/9/2020: Weaveworks venture capital transaction
Next: 12/9/2020: Luma Events venture capital transaction

Share this article

Where The Data Comes From

We report on tech company VC transactions. All VC database entries reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary